ACE Technology Guidances

ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the funding status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the funding recommendations, and key clinical and economic evidence which informed their deliberations. Plain English Summaries (PES) to explain ACE Technology Guidances are available for patients and the public.

Published on 02 Sep 2019
Last Updated on 02 Jan 2024
A- A+
Guidance Recommendations
The Ministry of Health's Drug Advisory Committee has recommended:
  • Ferric carboxymaltose 500 mg/10 mL solution for injection/infusion for treating iron deficiency anaemia when oral iron preparations are ineffective or cannot be used.

Subsidy status
Ferric carboxymaltose 500 mg/10 mL solution for injection/infusion is recommended for inclusion on the MOH Standard Drug List (SDL) for the abovementioned indication.

SDL subsidy does not apply to ferric carboxymaltose 100 mg/2 mL injection.

Ferric carboxymaltose for iron deficiency anemia (Updated 2 Jan 2024) Ferric carboxymaltose for iron deficiency anaemia Plain English Summary (2 Sep 2019)